RxDoctor Payments Data

Ioana Bielek

Gerontology · Marlboro, NJNPI 1861045825

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 24.6% of the total. Among gerontology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,892in general payments, 2019–2025

Across 244 payments — averaging $15.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$957
  • UCB, Inc.$902
  • Neurelis, Inc.$379
  • SK Life Science, Inc.$241
  • Pfizer$218
  • Lilly USA, LLC$191
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$3,892100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,892 in reported general payments places this provider in the 90th percentile of 374 gerontology providers in New Jersey.

See all gerontology providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
BriviactBrivaracetam43$94,403
XcopriCenobamate56$91,223
AptiomEslicarbazepine Acetate20$37,606
Nurtec OdtRimegepant Sulfate16$27,988
Lamotrigine ErLamotrigine46$23,845
QuliptaAtogepant17$18,123
Lacosamide127$10,407
Levetiracetam ErLevetiracetam71$6,026
Levetiracetam123$3,739
Topiramate13$2,634
Lamotrigine120$2,524
Donepezil Hcl58$1,744
Escitalopram Oxalate105$1,652
Memantine Hcl35$1,571
Divalproex Sodium ErDivalproex Sodium30$1,421

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
UCB, Inc.Briviact$902$94,40343 claims
SK Life Science, Inc.Xcopri$241$91,22356 claims
PfizerNurtec Odt$218$27,98816 claims
AbbVieQulipta$957$18,12317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 374 gerontology providers in New Jersey.

Other gerontology in Marlboro

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →